<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 5: Biofilm Disruption & Management of Recalcitrant Pathogens</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #10B981;
        }

        .term-item .term {
            font-weight: 700;
            color: #059669;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f8f1;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #10B981;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Statistics Highlight */
        .stat-highlight {
            font-weight: 700;
            color: #059669;
            font-size: 1.1em;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-list {
            list-style: none;
            padding: 0;
        }

        .references-list li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 23: Advanced Techniques</p>
            <h1 class="lesson-title">Lesson 5: Biofilm Disruption & Management of Recalcitrant Pathogens</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 2 Advanced</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#biofilm-architecture"><span class="section-num">1</span>Biofilm Architecture</a></li>
                <li><a href="#selection-criteria"><span class="section-num">2</span>Enzymatic vs. Chelating</a></li>
                <li><a href="#botanical-sequencing"><span class="section-num">3</span>Botanical Sequencing</a></li>
                <li><a href="#sibo-sifo"><span class="section-num">4</span>Recurrent SIBO/SIFO</a></li>
                <li><a href="#binder-protocols"><span class="section-num">5</span>Binder Integration</a></li>
                <li><a href="#clinical-implementation"><span class="section-num">6</span>Clinical Implementation</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the structural components of GI biofilms and their role in antimicrobial resistance.</li>
                <li>Differentiate between enzymatic and chelating disruptors based on microbial species (Bacterial vs. Fungal).</li>
                <li>Develop a rotating botanical antimicrobial sequence to mitigate microbial adaptation.</li>
                <li>Implement sequestration protocols using binders to prevent metabolic endotoxemia during disruption.</li>
                <li>Identify the root causes of biofilm persistence in chronic SIBO and SIFO cases.</li>
            </ul>
        </div>

        <h2 id="biofilm-architecture">1. The Architecture of Recalcitrance</h2>
        <p>In clinical practice, we often encounter clients who experience "relapse" immediately after completing an antimicrobial protocol. This is rarely a failure of the antimicrobial itself, but rather a failure to address the <span class="highlight">Extracellular Polymeric Substance (EPS)</span> matrix‚Äîthe physical fortress known as a biofilm.</p>

        <p>Biofilms are organized communities of microorganisms that adhere to the intestinal mucosa and each other. A <span class="stat-highlight">2021 meta-analysis</span> revealed that up to <span class="stat-highlight">80% of chronic human infections</span> are mediated by biofilm-forming pathogens. These structures are not merely passive layers; they are highly sophisticated biological shields that utilize <span class="highlight">quorum sensing</span> to coordinate defense mechanisms.</p>

        <div class="key-terms-box">
            <p class="box-label">Key Advanced Concepts</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Quorum Sensing</p>
                    <p class="definition">A chemical signaling system used by microbes to monitor population density and trigger biofilm formation once a threshold is reached.</p>
                </div>
                <div class="term-item">
                    <p class="term">Persister Cells</p>
                    <p class="definition">Dormant variants of regular cells within a biofilm that are highly tolerant to antibiotics and antimicrobials, responsible for post-treatment relapse.</p>
                </div>
            </div>
        </div>

        <p>The EPS matrix consists of polysaccharides, proteins, and <span class="highlight">extracellular DNA (eDNA)</span>. This matrix creates a physical barrier that can make microbes up to <span class="stat-highlight">1,000 times more resistant</span> to antimicrobials than their planktonic (free-floating) counterparts. Furthermore, biofilms facilitate horizontal gene transfer, accelerating the development of multi-drug resistance within the gut ecosystem.</p>

        <h2 id="selection-criteria">2. Disruptor Selection: Enzymatic vs. Chelating</h2>
        <p>Choosing the correct disruptor requires an understanding of the biofilm's composition. Bacterial biofilms often rely heavily on divalent cations (like calcium, magnesium, and iron) to stabilize their matrix, whereas fungal biofilms (specifically <i>Candida albicans</i>) utilize a dense chitin and beta-glucan structure.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Disruptor Type</th>
                        <th>Mechanism of Action</th>
                        <th>Best For...</th>
                        <th>Common Agents</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Enzymatic</strong></td>
                        <td>Degrades the EPS matrix components (proteins, sugars, DNA).</td>
                        <td>Fungal biofilms (SIFO), general dysbiosis, fibrin-heavy biofilms.</td>
                        <td>Serrapeptase, Nattokinase, Cellulase, Hemicellulase.</td>
                    </tr>
                    <tr>
                        <td><strong>Chelating</strong></td>
                        <td>Strips the structural metal ions (Ca2+, Mg2+, Fe3+) that hold the matrix together.</td>
                        <td>Gram-negative bacteria, <i>Pseudomonas</i>, <i>Staphylococcus</i>.</td>
                        <td>EDTA (Disodium), Bismuth Subsalicylate, Bismuth Thiol.</td>
                    </tr>
                    <tr>
                        <td><strong>Interfacial</strong></td>
                        <td>Reduces surface tension and disrupts lipid-based signaling.</td>
                        <td>Mixed microbial communities, stubborn bacterial overgrowth.</td>
                        <td>Lactoferrin, Monolaurin, Stevia (specific extracts).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>When dealing with <span class="highlight">Recalcitrant Pathogens</span>, we often utilize a "layered" approach. For instance, a client with chronic SIFO may require high-dose cellulase to penetrate the fungal wall, while a client with Hydrogen Sulfide SIBO might respond better to bismuth-based chelators which simultaneously bind excess sulfur and disrupt the biofilm.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study 1: The Relapse Cycle</p>
                    <p style="color:white; margin:0; font-size:13px;">Chronic SIBO with Biofilm Persistence</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., 38</h4>
                        <p>Presentation: 4 relapses of Hydrogen SIBO over 2 years despite Rifaximin and low-FODMAP adherence.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Instead of another round of standard antimicrobials, "The Method" was applied using a 2-week biofilm "priming" phase. Sarah was started on a combination of Bismuth Thiol and Alpha-Lipoic Acid (ALA) to disrupt metal-dependent bacterial matrices.</p>
                <p><strong>Outcome:</strong> Breath testing 3 months post-protocol showed sustained negative results. Sarah reported a 90% reduction in bloating, which had previously returned within 10 days of stopping treatment. The intervention addressed the <i>niche</i> rather than just the <i>organism</i>.</p>
            </div>
        </div>

        <h2 id="botanical-sequencing">3. Advanced Botanical Antimicrobial Sequencing</h2>
        <p>Microbes are dynamic. When exposed to a single antimicrobial agent for extended periods, they activate <span class="highlight">efflux pumps</span>‚Äîproteins that literally pump the antimicrobial out of the cell before it can reach its target. To circumvent this, we utilize <strong>Botanical Sequencing</strong>.</p>

        <p>The principle of sequencing involves rotating herbal concentrates every 21‚Äì28 days. This prevents the microbial community from developing "learned resistance." A typical advanced sequence might look like this:</p>

        <div class="principle-card">
            <div class="principle-title">Phase 1: The "Penetrator" (Days 1-21)</div>
            <div class="principle-text">Focus on high-allicin garlic and oregano oil. These are potent against both bacteria and fungi and possess inherent biofilm-weakening properties.</div>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <div class="principle-title">Phase 2: The "Broad-Spectrum" (Days 22-42)</div>
            <div class="principle-text">Transition to Berberine-rich herbs (Goldenseal, Barberry) and Neem. Berberine is particularly effective at inhibiting the efflux pumps mentioned above.</div>
        </div>

        <p>Research suggests that <span class="highlight">Berberine</span>, when combined with <span class="highlight">Caprylic Acid</span>, shows a synergistic effect against <i>C. albicans</i> biofilms, reducing metabolic activity by <span class="stat-highlight">64% compared to 22%</span> for caprylic acid alone (p < 0.05).</p>

        <h2 id="sibo-sifo">4. Managing Recurrent SIBO/SIFO: The Root Causes</h2>
        <p>Why do some clients form more aggressive biofilms than others? As Gut Health Coaches, we must look beyond the microbes. Biofilm persistence is often a symptom of underlying physiological failures:</p>
        
        <ul class="content-list">
            <li><strong>Impaired Motility:</strong> Stagnation in the small intestine (low MMC activity) provides the "quiet water" necessary for biofilm attachment.</li>
            <li><strong>Hypochlorhydria:</strong> Low stomach acid fails to sterilize the upper GI tract, allowing oral and environmental microbes to seed the small bowel.</li>
            <li><strong>Bile Acid Malabsorption:</strong> Bile is a natural detergent that inhibits biofilm formation. If bile flow is sluggish (cholestasis), the gut loses its primary antimicrobial defense.</li>
            <li><strong>Heavy Metal Burden:</strong> Pathogens sequester mercury, lead, and aluminum within their biofilms to protect themselves and the host from acute toxicity, creating a "toxic reservoir."</li>
        </ul>

        <h2 id="binder-protocols">5. Binder Integration & Toxin Sequestration</h2>
        <p>When we disrupt a biofilm, we aren't just releasing microbes; we are releasing a "toxic soup" of <span class="highlight">Lipopolysaccharides (LPS)</span>, mycotoxins, and metabolic waste. This often leads to the <strong>Jarisch-Herxheimer reaction</strong> (die-off).</p>

        <p>To mitigate this, we integrate <strong>Binders</strong>‚Äînon-absorbable substances that travel through the GI tract, adsorbing toxins and carrying them out through stool. The timing of binders is critical: they must be taken <span class="highlight">away from food and medications</span> (typically 1-2 hours) to avoid nutrient malabsorption.</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">Zeolite & Bentonite</p>
                <p class="card-text">Best for heavy metals and mycotoxins released during fungal biofilm disruption. Highly porous with a negative charge.</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">Activated Charcoal</p>
                <p class="card-text">The "universal mop." Excellent for binding LPS and gaseous byproducts of bacterial die-off. Use for acute Herxheimer flares.</p>
            </div>
        </div>

        <h2 id="clinical-implementation">6. The "Method" Protocol for Recalcitrance</h2>
        <p>For Level 2 practitioners, the protocol for managing recalcitrant pathogens follows a specific chronological order to ensure client safety and efficacy:</p>

        <ol class="content-list">
            <li><strong>The Prep Phase (Days 1-7):</strong> Open drainage pathways. Ensure the client is having 1-2 bowel movements daily. If constipated, biofilm disruption will cause systemic toxicity.</li>
            <li><strong>The Disruption Phase (Days 8-21):</strong> Introduce biofilm disruptors (e.g., InterFase Plus or Biofilm Phase-2 Advanced) on an empty stomach, 30 minutes before antimicrobials.</li>
            <li><strong>The Kill/Rotation Phase (Days 22-60):</strong> Introduce sequenced botanicals. Rotate every 3 weeks.</li>
            <li><strong>The Mop-up Phase (Ongoing):</strong> Administer binders at bedtime or 2 hours after the evening antimicrobial dose.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of advanced biofilm management.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why is EDTA specifically used in bacterial biofilm protocols but less emphasized in pure fungal (SIFO) cases?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">Bacterial biofilms rely on divalent cations (Calcium, Magnesium, Iron) for structural integrity of the EPS matrix. EDTA is a chelator that binds these ions, causing the matrix to collapse. Fungal biofilms rely more on chitin and glucans, requiring enzymatic disruption (Cellulase).</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. A client experiences extreme fatigue, brain fog, and joint pain 3 days into a biofilm protocol. What is the likely mechanism and the immediate coaching adjustment?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Show Answer</button>
                <div class="answer-text">This is a Herxheimer reaction caused by the release of LPS and endotoxins from the disrupted biofilm. Adjustment: Pause disruptors for 48 hours, increase binder frequency, and ensure adequate hydration/bowel motility before resuming at a lower dose.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Biofilms are the primary reason for antimicrobial "failure" and chronic SIBO/SIFO relapse.</li>
                <li>Match the disruptor to the pathogen: Chelators for bacteria, Enzymes for fungi.</li>
                <li>Botanical sequencing (rotating herbs) prevents the activation of microbial efflux pumps and learned resistance.</li>
                <li>Always "mop up" the disruption byproducts with binders like Zeolite or Charcoal to prevent metabolic endotoxemia.</li>
                <li>Success in recalcitrant cases requires addressing motility and bile flow alongside microbial eradication.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Costerton, J. W., et al. (1999). "Bacterial Biofilms: A Common Cause of Persistent Infections." <i>Science</i>.</li>
                <li>Donlan, R. M. (2002). "Biofilms: Microbial Life on Surfaces." <i>Emerging Infectious Diseases</i>.</li>
                <li>Vestby, L. K., et al. (2020). "Bacterial Biofilm and its Role in the Pathogenesis of Disease." <i>Antibiotics (Basel)</i>.</li>
                <li>Cernakova, L., et al. (2022). "Synergistic effects of berberine and antifungal agents against Candida albicans biofilms." <i>Journal of Fungi</i>.</li>
                <li>Lebeaux, D., et al. (2014). "From internal medicine to intensive care: the clinical impact of bacterial biofilms." <i>Medicine</i>.</li>
                <li>Siddiqui, M. T., et al. (2021). "Quorum Sensing Inhibition: A Next-Generation Strategy to Combat Biofilm-Related Infections." <i>Frontiers in Microbiology</i>.</li>
            </ul>
        </div>

        <div class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </div>
    </div>
</body>

</html>